+ Watch ASTX
on My Watchlist
A pharmaceutical company dedicated to the discovery, development and commercialization of therapies to treat patients with cancer.
I like ASTX as a speculative play. It is one of the rare small BioTechs that is actually profitable. It has several drugs in the pipeline and one (Dacogen) already approved and selling. It sold off a few months ago when the FDA did not approve Dacogen for alternative treatment but is now oversold considering it's pipeline, fantastic balance sheet with zero debt, and recent royalty from JNJ for hitting targets on a joint venture. A lot to like here for a spec play.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions